Study guide
5.1 Negative Pressure Wound Therapy Readiness and Monitoring
Wound Care Certified WCC
Track your progress as you read
Finished sections get a check mark.
1 Orientation: NAWCO WCC Exam, Eligibility, and Scoring
1.1 Credential Purpose, Sponsor, and Scope 1.2 Qualifying License and Eligibility Frame 1.3 Education and Experience Pathways 1.4 Exam Format, Delivery, and Timing 1.5 Scoring, Standard Setting, and Confidentiality 1.6 Fees, Scheduling, Retesting, and Recertification
2 Wound Assessment: Etiology, Status, and Skin Integrity
2.1 Assessment Domain and Exam Approach 2.2 Etiology Patterns and Location Clues 2.3 Wound Status: Measurement, Tissue, and Exudate 2.4 Depth, Tissue Loss, and Pressure Injury Language 2.5 Skin Structure, Function, and Barrier 2.6 Skin Integrity Across the Lifespan
3 Patient Assessment: Labs, Nutrition, Pain, and Risk Tools
3.1 Labs and Diagnostic Data in Wound Assessment 3.2 Nutrition, Hydration, and Healing Risk 3.3 Comorbidities, Medications, and Current Condition 3.4 Psychosocial History, Adherence Barriers, and Access 3.5 Pain Assessment Tools and Treatment Tolerance 3.6 Risk Tools, Cognition, Function, and ADLs
4 Treatment Foundations, Dressings, and Wound Bed Preparation
4.1 Cleansing, Wound Hygiene, and Assessment Before Treatment 4.2 Moisture Balance and Core Dressing Functions 4.3 Dressing Categories, Formulary, and Resource Fit 4.4 Periwound Protection, Exudate, and Securement 4.5 Wound Bed Preparation and Debridement Concepts 4.6 Infection Signs, Prevention, and Escalation
5 Advanced Therapies, Diagnostics, Support Surfaces, and Referrals
5.1 Negative Pressure Wound Therapy Readiness and Monitoring 5.2 Electrical Stimulation, Ultrasound, and Topical Adjuncts 5.3 Diagnostics, Cultures, Labs, and Referral Triggers 5.4 Support Surfaces, Pressure Redistribution, and Microclimate 5.5 Offloading, Compression, and Lymphedema Decision-Making 5.6 Hyperbaric Oxygen and Specialty Referral Coordination
6 Infection, Vascular, Diabetic, and Pressure Injury Scenarios
6.1 Local, Spreading, and Systemic Infection Signals 6.2 Biofilm, Colonization, Culture, and Antimicrobial Traps 6.3 Diabetic Foot Ulcer Scenarios: Neuropathy, Perfusion, and Offloading 6.4 Venous, Arterial, and Mixed Vascular Wound Scenarios 6.5 Pressure Injury Prevention, Staging, and Treatment Scenarios 6.6 Integrated Contraindication and Priority Scenarios
7 Reevaluation, Healing Progression, and Treatment Adjustment
7.1 Re-Evaluation Domain and Decision Cycle 7.2 Treatment Choice and Plan Effectiveness 7.3 Weekly Measurement and Trend Monitoring 7.4 Tolerance, Pain, and Treatment Reactions 7.5 Adherence Barriers and Plan Adjustment 7.6 Healing Phases and Progression Decisions
8 Education, Health Literacy, and Interprofessional Teaching
8.1 Education Domain Scope and Priorities 8.2 Patient and Family Treatment-Plan Teaching 8.3 Health Literacy, Plain Language, and Teach-Back 8.4 Language, Cognition, Sensory Needs, and Cultural Adaptation 8.5 Discharge Teaching and Home Adherence 8.6 Interprofessional Team Teaching and Prevention Reinforcement
9 Administration, Protocols, Data Quality, and Care Coordination
9.1 Administration Domain Map for WCC Candidates 9.2 Evidence-Based Protocols and Facility Processes 9.3 Formularies, Product Access, and Treatment-Plan Workflow 9.4 Educational Media and Team Communication Tools 9.5 Data Quality, Prevalence, Incidence, and Outcome Monitoring 9.6 Payers, Case Management, and Transition Coordination
10 Legal Documentation, Ethics, Scope, and Patient Autonomy
10.1 Legal Domain Map for WCC Candidates 10.2 Objective Wound-Characteristic Documentation 10.3 Treatment-Plan Documentation and Continuity 10.4 Scope of Practice, Regulatory Issues, and Consultation 10.5 Ethics, Culture, Palliative Care, and Patient Autonomy 10.6 Confidentiality, Record Integrity, and Exam Conduct
11 Risk, Prevention, At-Risk Populations, and Product Selection
11.1 Risk Framework for Impaired Skin Integrity 11.2 Pressure Prevention, Repositioning, and Support Surfaces 11.3 Moisture, Incontinence, and Periwound Protection 11.4 Offloading, Foot Risk, and At-Risk Populations 11.5 Product Indications, Contraindications, and Selection 11.6 Population-Specific Prevention Across Settings
12 Integrated WCC Case Scenarios and Final Review
12.1 Blueprint-Weighted Final Review Strategy 12.2 Integrated Pressure Injury Case Review 12.3 Integrated Diabetic Foot and Vascular Case Review 12.4 Integrated Venous Leg Ulcer and Compression Case Review 12.5 Legal, Education, and Administration Integrated Cases 12.6 Exam Day, Scoring, Retake, and Recertification Review
5.1 Negative Pressure Wound Therapy Readiness and Monitoring
Key Takeaways Explain This Topic AI
Negative pressure wound therapy (NPWT) is an adjunctive treatment topic inside the WCC Treatment domain, which is 25% of the 100 scored questions.
WCC scenarios test whether the wound is appropriate, the order is clear, the seal is maintained, and reassessment is documented.
NPWT does not replace debridement, infection control, pressure redistribution, nutrition review, or referral, and is contraindicated over untreated necrotic tissue, malignancy, untreated osteomyelitis, and exposed vessels or organs.
A common exam trap is choosing NPWT before addressing necrosis, untreated infection, exposed structures, or the underlying cause of tissue damage.
Last updated: June 2026
NPWT as an adjunct, not a shortcut
The WCC blueprint, administered by the National Alliance of Wound Care and Ostomy (NAWCO/NAWCCB), places adjunctive therapies in the Treatment domain (25% of the 100 scored questions) . So negative pressure wound therapy (NPWT) appears as a clinical-decision item, not device trivia. The exam asks whether you can connect the therapy to wound bed readiness, exudate control, cause control, documentation, and referral.
NPWT, also called vacuum-assisted closure, uses a sealed foam or gauze filler, an occlusive drape, and a suction pump to apply subatmospheric pressure. Typical continuous settings run -75 to -125 mmHg , with -125 mmHg common for foam over large granulating wounds and lower pressures (-50 to -75 mmHg) for fragile tissue, grafts, or painful wounds. Suction removes exudate, reduces edema, increases local perfusion, and promotes granulation and wound contraction. Dressing changes occur roughly every 48 to 72 hours; foam left in place too long ingrows into granulation tissue and becomes painful to remove.
Indications versus contraindications
NPWT decision point Appropriate (proceed/monitor) Stop / do NOT apply
Wound bed Clean granulating base, moderate-to-heavy exudate, dehisced surgical wound, stage 3/4 pressure injury, flap or graft bolster Untreated necrotic eschar, untreated osteomyelitis, malignancy in the wound, untreated infection
Exposed structures Protected with contact layer per order Exposed blood vessels, anastomoses, organs, or nonenteric/unexplored fistulae
- Bleeding risk Hemostasis achieved Active bleeding or anticoagulation with uncontrolled oozing
- Order and scope Provider order with pressure/mode specified Candidate tempted to start independently
Seal/pressure Drape compressed, no leak, pump holds therapy Hissing, collapsed tubing, lifting drape, persistent leak alarm
Exposed vessels and untreated necrosis are the classic absolute-contraindication distractors. NPWT over a friable vessel can cause life-threatening hemorrhage, which is why bright-red canister filling is an emergency, not a maintenance finding.
Applied WCC scenario
A dehisced abdominal surgical wound has a clean granulating bed, moderate serosanguineous drainage, and a provider order for foam NPWT at -125 mmHg continuous. The best answer: protect the periwound with a skin prep or hydrocolloid frame, place the contact layer and foam to fill (not overlap intact skin), confirm the seal and therapeutic pressure, log canister output, and schedule reassessment in 48 to 72 hours. If the stem then adds spreading erythema, new fever, foul odor, exposed bowel, or sudden bright-red output, the answer pivots to stop suction, cover the wound, notify the provider, and refer .
Documentation and monitoring
Document wound measurements, tissue type, exudate volume and color, odor, periwound condition, dressing/foam type, ordered pressure and mode (continuous vs intermittent), seal status, output amount and character, pain, patient education, and response to alarms. This supports the Re-Evaluation (16%) and Legal (6%) domains because the next clinician must continue safely. A leak alarm means therapy is not being delivered , so treat it as loss of treatment, not a nuisance.
Exam traps
Picking NPWT because the wound is large while ignoring untreated infection, ischemia, exposed structures, or an uncontrolled cause.
Treating sudden bright-red drainage as routine instead of escalating for possible hemorrhage.
Forgetting that a plantar diabetic ulcer still needs offloading and a venous ulcer still needs perfusion-appropriate edema control during NPWT.
Read NPWT items in sequence: identify etiology, inspect the bed, screen for contraindications and urgent referral signals, verify the order and pressure setting, then choose monitoring and reassessment. The correct answer protects safety and scope before optimizing the device.
Continuous versus intermittent and special modes
Continuous suction is the usual starting mode and is preferred for fresh wounds, fragile tissue, tunneling, and graft or flap bolsters because steady pressure maintains the seal and limits movement. Intermittent or variable (cyclic) suction may stimulate more granulation in select chronic wounds but is more painful and harder to keep sealed, so it is rarely the first choice. NPWT with instillation (NPWTi-d) periodically dwells a topical solution (often normal saline or an antiseptic) in the wound before suctioning, and is reserved for heavily contaminated or infected wounds under specialist direction.
On the exam, do not select an exotic mode unless the stem and order support it; default reasoning favors continuous suction at the ordered pressure with a maintained seal.
Periwound protection and common complications
Maceration of the periwound from a poorly sized drape or pooled exudate is a frequent, testable complication. Frame intact skin with a skin protectant, hydrocolloid, or thin film so the foam contacts only the wound bed. Other complications to recognize include foam ingrowth when changes are delayed beyond 72 hours, retained foam pieces (always count foam in and foam out), pressure or pain over a bony prominence under the drape, and periwound blistering from shear when the drape is stretched. Each of these is corrected within scope and documented, not ignored.
Tolerance, education, and discontinuation
Patient and caregiver education is part of every NPWT item: how the pump works, what the alarms mean, expected drainage color and volume, what to report (bright-red bleeding, soaked dressing, fever, increasing pain), and the importance of keeping the device powered and the canister upright. Therapy should be paused or reconsidered when the wound is no longer progressing, the patient cannot tolerate the pressure, or the wound has healed enough that a simpler dressing suffices. NPWT is a bridge to closure, not a permanent dressing, and the WCC plan always names the next reassessment point.